irritable bowel syndrome
- CME Offerings
- Featured Programs
- Symposia
- Webcasts
- eMonographs
- Audiocasts
- Live Dinner Meetings
Content available soon!
Archived Symposia Broadcasts
Great Debates in Functional GI Disorders: Discussing the Clinical Implications of Fecal Incontinence and IBS
Brooks Cash, MD; Lin Chang, MD; Philip Schoemfeld, MD; William D.Chey, MD. Mark Pimental, MD
Recorded CME Event
Gi News Tonight: Clinical Updates in IBS
Nicholas Talley, MD; William Chey, MD; Lin Chang, MD; Mark Pimentel, MD; Philip Schoenfeld, MD
Recorded CME Event
Trial by Jury: Examining the ACG Position Statement on the Management of IBS
Stephen B. Hanauer, MD; Maria T. Abreu, MD; Edward Loftus, MD; Scott Plevy, MD
Recorded CME Event
Prime Time Live: The Clinical Implications of IBS
Nicholas Talley, MD; William Chey, MD; Lin Chang, MD; Mark Pimentel, MD; Philip Schoenfeld, MD
Recorded CME Event
Xpert Perspectives on IBS from DDW 2018 in Washington, DC
Mark Pimentel, MD; William D. Chey, MD;
Didactic Lecture
The Role of the Microbiome in Health and Disease
Mark Pimentel, MD; Janelle C. Arthur, PhD; Mark S. Riddle, MD, DrPH; Gary D. Wu, MD
Didactic Lecture
Holistic Approach to Diagnosis and Management of Irritable Bowel Syndrome
Amy Kassebaum, PA-C
Didactic Lecture
Opioid Induced and Exacerbated Constipation Importance, Definitions and Rationale for a Change in Nomenclature
Amy Kassebaum, PA-C
Didactic Lecture
Small Intestinal Bacterial (SIBO) and Fungal Overgrowth (SIFO)
Nicole Martinez de Andino, RD, APRN
Didactic Lecture
Behavioral Medicine for Digestive Health
Sarah Quinton, PsyD
Didactic Lecture
Trial By Jury
Brooks Cash, MD; William D. Chey, MD; Anthony Lembo, MD; Baha Moshiree, MD; Mark Pimentel, MD
Didactic Lecture
IBS Prime
Brooks Cash, MD; Philip Schoenfeld, MD;
Didactic Lecture
Xpert Perspectives on IBS from ACG/WCOG in Orlando
William D. Chey, MD; Brian E. Lacy, MD; Mark Pimentel, MD
Didactic Lecture
Xpert Perspectives on OIC from DDW 2017 in Chicago, IL
William D. Chey, MD
Didactic Lecture
Negative Effects of Opioids on the Gastrointestinal Tract and The Development of Newer Therapeutics To Overcome Them
Darren M. Brenner, MD
Didactic Lecture
Optimizing Management of IBS-C and CIC
Nicholas J. Talley, MD (chair), Darren M. Brenner, MD, William D. Chey, MD, Philip S. Schoenfeld, MD
Didactic Lecture
Improving Patient Outcomes in IBS-D: New Evidence on Epidemiology, Pharmacology, and Mgmt
Lin Chang, MD (chair), William D. Chey, MD, FACG, AGAF, FACP, RFF, Mark Pimentel, MD, FRCP(C), Philip S. Schoenfeld, MD, MSEd, MSc (Epi)
Didactic Lecture
Beyond Gut Instincts: Applying the latest IBS advances to practice
William D. Chey, MD, Stanley A Cohen, MD, Nicholas Talley, MD, Mark Pimentel, MD, Philip S. Schoenfeld, MD
Didactic Lecture
Functional dyspepsia: A new disease model
Nick Talley, MD
Didactic Lecture
Integrating Novel Diagnostic Strategies into Practice: Key Points
Stanley Cohen, MD
Didactic Lecture
Novel Strategies for IBS-C
Mark Pimentel, MD
Didactic Lecture
Management of Severe Constipation: Dysnnergic Defecation and OIC
Philip Schoenfeld, MD
Didactic Lecture
Which Diet is Right for IBS?
William Chey, MD
Didactic Lecture
Emerging Medical Management Options for IBS-D
William Chey, MD
Didactic Lecture
Overview of IBS-C Therapies
Christine Frissora, MD
Didactic Lecture
A Primer on the Diagnosis and Management of Functional Dyspepsia
Brian Lacy, MD
Didactic Lecture
Distinguishing Celiac Disease, Non-Gluten Sensitivity and IBS
Lucinda Harris, MD
Didactic Lecture
Understanding and Managing Gastroparesis
Linda Nguyen, MD
Didactic Lecture
Opioid-Induced Bowel Dysfunction
Darren Brenner, MD
Didactic Lecture
Xpert Perspectives: New Insights into the Recognition and Management of FGIMDs 2015
Brooks Cash, MD, William Chey, MD, Mark Pimentel, MD
Didactic Lecture
Gi News Tonight: Case Discussions on Functional GI and Motility Disorders
Lawrence Schiller, MD, Lin Chang, MD, Mark Pimentel, MD, Philip Schoenfeld, MD
Didactic Lecture
Understanding and Managing IBS and CIC in the primary care setting
1.0 AMA PRA Category 1 Credit(s)™
An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice
1.0 AMA PRA Category 1 Credit(s)™
Advances in IBS
1.0 AMA PRA Category 1 Credit(s)™
IBS News Tonight
1.0 AMA PRA Category 1 Credit(s)™
Gastroparesis: Diagnosis and Management
1.0 AMA PRA Category 1 Credit(s)™
Managing the Gastrointestinal Effects of Opioids
1.0 AMA PRA Category 1 Credit(s)™
Implementing Effective Patient Communication Skills in IBS
1.0 AMA PRA Category 1 Credit(s)™
Advances in the Management of FGIDs
The management of functional gastrointestinal disorders (FGIDs)—which encompass a broad range of conditions that are characterized by persistent, recurrent symptoms in the absence of clear structural abnormalities1 has undergone a major shift in the past decade, from poorly recognized, often misunderstood symptom complexes to conditions with clear diagnoses and better delineated treatment pathways. Nowhere is this better illustrated than in the increasing pace of original research publications and abstracts at major international meetings focusing on FGIDs. This monograph serves as a summary of highlights from 2013 meetings and literature focusing on these common and clinically consequential disorders.
Gut Microbes: Role in Health and GI Related Disorders
In this supplement, the importance of gut microflora in human health and disease is examined. Emphasis is placed on novel topics with recent discoveries that will guide the future of this area. Yet, it is important to remember that we have a symbiotic relationship with our gut colonists. For Charles Darwin once stated, "In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have prevailed." Please click on the selection to view the entire supplement.
- GI News & Library
- Reuters News
- Journal Abstracts
- Slide Library
- Congress Calendar
- Naturopathic Approaches to Irritable Bowel Syndrome-A Delphi Study
- Fecal microbiota transfer for bowel disorders: efficacy or hype?
- Clinical application of dietary therapies in irritable bowel syndrome
- Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation
- Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study
- Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
- Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey
- Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome
- The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea
- Symptoms and dietary practices of irritable bowel syndrome patients compared to controls: results of a United States National survey
- A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults
- Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable
- Reduced Symptoms of Post-traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans
- Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
- Pre- and probiotic overview
- Review article: an analysis of safety profiles of the treatments for diarrhoea-predominant irritable bowel syndrome
- Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis
- Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports
- Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease
- Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic
- Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome
- Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome
- A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome
- Association between 2 painful and poorly understood conditions: irritable bowel and sensitive skin syndromes
- The gut microbiome and irritable bowel syndrome
- Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists
- Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders
- Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics
- Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease
- The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs
- Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome
- Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians
- Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome
- Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study
- Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint
- Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis
- A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study
- Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine
- Implications of Pharmacogenomics to the Management of IBS
- The "Biology-First" Hypothesis: Functional disorders may begin and end with biology-A scoping review
- Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
- Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States
- Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome
- Use of Sourdough in Low FODMAP Baking
- No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease
- Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire
- Refractory Constipation: What is the Clinician to Do?
- Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome
- Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
- Implications of Pharmacogenomics to the Management of IBS
- Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study
- Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review
- Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics
- The role of diet in the management of irritable bowel syndrome: a focus on FODMAPs
- Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine
- Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint
- Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation
- Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update
- The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis
- Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review
- Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome
- Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study
- Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome
- Pediatric Irritable Bowel Syndrome: Perspectives on Pain and Adolescent Social Functioning
- No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease
- Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States
- Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments
- Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
- Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms
- Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome
- Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea
- Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study
- Health problems associated with irritable bowel syndrome: analysis of a primary care registry
- Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome
- Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview
- Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus
- Functional Bowel Disorders Gastroenterology's 75th anniversary
- Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials
- Functional Gastrointestinal Disorders: Functional Lower Gastrointestinal Disorders in Adults
- Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Santé study
- Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals
- Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation
- Development of Irritable Bowel Syndrome Features Over a 5-year Period
- Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome
- The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review
- Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
- Fermentable short chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for vegetarian- and vegan-based eating patterns
- Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV
- Research Design Characteristics of Published Pharmacologic Randomized Clinical Trials for Irritable Bowel Syndrome and Chronic Pelvic Pain Conditions: an Acttion Systemic Review
- Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis
- The Role of Diet in the Treatment of Irritable Bowel Syndrome: A Systematic Review
- Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome
- Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome
- Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions
- Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution
- The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice
- Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study
- Layperson's knowledge and perceptions of irritable bowel syndrome as potential barriers to care
- Best uses of osteopathic manipulation
- Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome
- Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?
- The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome
- Evidence-based management of irritable bowel syndrome with diarrhea
- Wake-up Call to Clinicians: The Impact of Sleep Dysfunction on Gastrointestinal Health and Disease
- Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation
- Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide
- The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
- Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research
- New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond
- Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study
- The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome(IBS)
- Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education
- The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update
- Stress & the gut-brain axis: Regulation by the microbiome
- Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance
- Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?
- Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?
- Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial
- Celiac disease is uncommon in irritable bowel syndrome in the USA
- An update on prucalopride in the treatment of chronic constipation
- Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis
- Medicinal Foods for Functional GI Disorders
- Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment
- Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome
- Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions
- Pharmacotherapy for Irritable Bowel Syndrome
- New therapies in Irritable Bowel Syndrome: what works and when
- Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
- AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome
- The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study
- Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
- Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome
- Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response
- General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study
- Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
- Role of G protein-coupled receptors-microRNA interactions in Gastrointestinal Pathophysiology
- The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome
- Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients
- Complementary and Integrative Gastroenterology
- Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients
- Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
- The global impact of IBS: time to think about IBS-specific models of care?
- Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes
- The place of eluxadoline in the management of irritable bowel syndrome with diarrhea
- Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article
- Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by ?-Galactosidase Treatment
- Irritable bowel syndrome and diet: where are we in 2018?
- Prokinetics in the Management of Functional Gastrointestinal Disorders
- Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease
- Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts
- Clopidogrel IBS Patients Have Higher Incidence of Gastrointestinal Symptoms Influenced by Age and Gender
- Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?
- A psychology of the human brain-gut-microbiome axis
- Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome with Eluxadoline
- Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome
- Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population
- Advances in IBS 2016: A Review of Current and Emerging Data
- A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset
- Rifamycins, Alone and in Combination
- Modern Management of Irritable Bowel Syndrome: More Than Motility
- British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update)
- Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk
- Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment
- Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation
- Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness
- Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome
- Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomised controlled trial
- Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
- Inflammation in irritable bowel syndrome: Myth or new treatment target?
- Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
- Hot Topics in Primary Care: Individualizing Pharmacologic Management of Irritable Bowel Syndrome
- Is irritable bowel syndrome an infectious disease?
- Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
- The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
- Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders
- Rifaximin and Eluxadoline - Newly Approved Treatments for Diarrhea-Predominant Irritable Bowel Syndrome: What is Their Role in Clinical Practice Alongside Alosetron?
- Managing irritable bowel syndrome in primary care
- Probiotics in Irritable Bowel Syndrome: The Science and the Evidence
- New and Emerging Treatment Options for Irritable Bowel Syndrome
- Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion
- Irritable Bowel Syndrome and Microscopic Colitis: a Systematic Review and Meta-analysis
- Irritable bowel syndrome in patients with quiescent inflammatory bowel disease. A review
- Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the
- Gender differences in irritable bowel syndrome: the interpersonal connection
- Increased Risk of Functional Gastrointestinal Sequelae Following Clostridium difficile infection among Active Duty United States Military Personnel (1998-2010)
- A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms
- Diet low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
- Diagnostic outcomes following childhood non-specific abdominal pain: a record-linkage study
- Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis
- RIFAXIMIN: THE REVOLUTIONARY ANTIBIOTIC APPROACH FOR IRRITABLE BOWEL SYNDROME
- Prokinetics in the Management of Functional Gastrointestinal Disorders
- Pharmacogenetics in irritable bowel syndrome
- Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity
- Drug discovery approaches to irritable bowel syndrome
- Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults
- Symbiotics in irritable bowel syndrome - better than probiotics alone?
- Disability in Children and Adolescents with Irritable Bowel Syndrome and/or Fibromyalgia
- A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS
- Irritable Bowel Syndrome: Modern Concepts and Management Options
- Irritable bowel syndrome: an integrated explanatory model for clinical practice
- Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome
- The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease
- Irritable bowel syndrome: new and emerging treatments
- Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers
- Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina
- Is fructose malabsorption a cause of irritable bowel syndrome?
- Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina
- Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome
- Evidence Against Routine Testing of Patients with Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study
- Current and Emerging Treatments for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: Focus on Prosecretory Agents
- Pediatric Functional Constipation Gastrointestinal Symptom Profile Compared to Healthy Controls
- Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome
- Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome
- New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics
- A systematic review of integrated traditional chinese and Western medicine for managing irritable bowel syndrome
- Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology
- Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea
- Obesity and irritable bowel syndrome: a comprehensive review
- Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea
- A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome
- Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis
- Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009
- New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin
- The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
- Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder
- Irritable bowel syndrome: a clinical review
- Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients
- High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria
- Abdominal pain endpoints currently recommended by the FDA and EMA for adult patients with irritable bowel syndrome may not be reliable in children
- Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea
- Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome
- Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease
- Irritable bowel syndrome: an integrated explanatory model for clinical practice
- A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS
- Irritable Bowel Syndrome: Modern Concepts and Management Options
- Lubiprostone in constipation: clinical evidence and place in therapy
- Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009
- A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome
- Deficient habituation to repeated rectal distensions in irritable bowel syndrome patients with visceral hypersensitivity
- The Science, Evidence and Practice of Dietary Interventions in Irritable Bowel Syndrome
- Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study
- The Effect of Emotional Stress and Depression on the Prevalence of Digestive Diseases
- Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study
- Stress and chronic pelvic pain
- Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder
- A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
- Risk for irritable bowel syndrome in fibromyalgia patients: a national database study
- Chronic multisymptom illness among female veterans deployed to iraq and afghanistan
- The rise and fall of gluten!
- Functional gastrointestinal disorders in 35 447 adults and their association with body mass index
- IBS-like symptoms in patients with ulcerative colitis
- Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients
- Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review
- Rifaximin: irritable bowel syndrome
- Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases
- Genetic polymorphism in pathogenesis of irritable bowel syndrome
- Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report
- Perceived risk as a barrier to appropriate diagnosis of irritable bowel syndrome
- Optimizing Management of IBS-C and CIC: How Far Have We Come and Where Are We Going?
- Improving Patient Outcomes in IBS-D: New Evidence on Epidemiology, Pharmacology, and Management
- An Evidence-based Approach to IBS and CIC: Applying New Advances to Daily Practice
- Functional dyspepsia: A new disease model
- Integrating Novel Diagnostic Strategies into Practice: Key Points
- Novel Strategies for IBS-C
- Beyond Gut Instincts: Applying the Latest IBS Advances to Practice
- Advances in IBD Orlando, FL
- Crohn's & Colitis Congress Las Vegas, NV
- European Crohn's and Colitis Organisation Copenhagen/Denmark
- Digestive Disease Week San Diego, CA
- ACG 2019 Annual Scientific Meeting and Postgraduate Course San Antonio, Texas
December 13-15, 2018
February 7-9, 2019
March 6-9, 2019
May 18-21, 2019
October 25-30, 2019
© Copyright 2013-2018 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.
